From study so far conducted, ALS TDI believes that targeting CD40L is a potential therapeutic approach for ALS. ALS TDI offers studied a commercially obtainable research reagent that targets CD40L in a preclinical disease model of ALS . The outcomes, that have been published in Character Genetics this year 2010, demonstrated that the antiCD40L research reagent slowed paralysis and improved survival in the pre-clinical SOD1 model. Related StoriesNew research offers prospect of early intervention to prevent neurodegenerative diseasesJanssen signs license contract with Alligator Bioscience for immuno-oncology antibodyCalcitonin-gene related peptide antibody inhibition displays migraine avoidance promiseUnder the terms of this agreement, ALS TDI will test a murine surrogate of CDP7657 in the SOD1 model.It was just so heavy and so tight, Atlanta resident Deborah Greene told CBS Information correspondent Mark Strassmann. The high pollen counts are due to a lack of rainfall, which scrubs pollen from the new air. The majority of the pollen can be coming from pine trees. Allergy sufferers are being suggested to limit their outdoor activities through the early morning, when pollen is at its worst. About 25 to 35 % of the population, the adult population, has this predisposition to possess sensitivities to pollen allergy, allergist Dr.